{"id":1421,"date":"2023-08-26T03:08:23","date_gmt":"2023-08-26T01:08:23","guid":{"rendered":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/"},"modified":"2023-08-26T03:08:24","modified_gmt":"2023-08-26T01:08:24","slug":"limmunotherapie-a-arnm-cible-le-cancer-linkidoc","status":"publish","type":"post","link":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/","title":{"rendered":"L&rsquo;immunoth\u00e9rapie \u00e0 ARNm cible le cancer |  Linkidoc"},"content":{"rendered":"<div>\n<p>Des chercheurs de l\u2019H\u00f4pital Mount Sinai ont d\u00e9velopp\u00e9 un traitement contre le cancer bas\u00e9 sur l\u2019ARNm.  L\u2019approche combine l\u2019administration d\u2019une th\u00e9rapie par ARNm dans des nanoparticules lipidiques et implique \u00e9galement la co-administration de cellules dendritiques qui ont \u00e9galement \u00e9t\u00e9 amorc\u00e9es par un traitement avec un ARNm enrob\u00e9 dans des lipides.  La technologie vise \u00e0 surmonter certaines des astuces d\u2019\u00e9vasion immunitaire que les tumeurs utilisent pour contourner le syst\u00e8me immunitaire, dont certaines peuvent entraver les immunoth\u00e9rapies plus traditionnelles.  En revanche, ce traitement, que les chercheurs ont appel\u00e9 CATCH, vise \u00e0 faire progresser le cycle immunitaire du cancer en modulant le microenvironnement tumoral pour soutenir une r\u00e9ponse immunitaire anticanc\u00e9reuse.     <\/p>\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><noscript><img decoding=\"async\" fetchpriority=\"high\" width=\"656\" height=\"161\" src=\"https:\/\/www.linkidoc.fr\/blog\/wp-content\/uploads\/2023\/08\/Limmunotherapie-a-ARNm-cible-le-cancer-Linkidoc.jpg\" alt=\"\" class=\"wp-image-1551225\"  \/><\/noscript><\/figure>\n<\/div>\n<p>Les immunoth\u00e9rapies modernes peuvent avoir une efficacit\u00e9 significative dans divers cancers, mais elles ne r\u00e9ussissent pas toujours.  Les tumeurs utilisent diverses astuces pour se dissimuler du syst\u00e8me immunitaire ou supprimer son activit\u00e9 de reconnaissance et de destruction des cellules canc\u00e9reuses.  Un type de cellules qui peut \u00eatre mobilis\u00e9 dans la lutte contre le cancer sont les cellules dendritiques, qui peuvent \u00ab\u00a0\u00e9duquer\u00a0\u00bb les cellules T sur les cellules \u00e0 cibler.  Cependant, les traitements ciblant les cellules dendritiques ont connu un succ\u00e8s mitig\u00e9 en raison du comportement immuno-\u00e9vasif des tumeurs.<\/p>\n<p>\u00ab\u00a0La plupart des approches visant \u00e0 renforcer ce r\u00f4le critique des cellules dendritiques &#8211; ou th\u00e9rapies cellulaires adoptives &#8211; visent \u00e0 augmenter les signaux d&rsquo;activation fournis aux cellules dendritiques lorsque des mol\u00e9cules sp\u00e9cifiques \u00e0 leur surface se lient aux cellules tumorales\u00a0\u00bb, a d\u00e9clar\u00e9 Yizhou Dong, chercheur impliqu\u00e9 dans l&rsquo;\u00e9tude.  \u00ab Cependant, ces essais cliniques n\u2019ont pas eu autant de succ\u00e8s qu\u2019esp\u00e9r\u00e9.  En effet, les tumeurs ont tendance \u00e0 \u00e9voluer de diff\u00e9rentes mani\u00e8res pour interrompre chaque \u00e9tape du cycle cancer-immunit\u00e9.<!-- ASYNC UAT M - 300x250(t,r) - --><\/p>\n<p><!-- END ASYNC UAT M - 300x250(t,r) --><\/p>\n<p>Le syst\u00e8me CATCH int\u00e8gre une attaque \u00e0 deux volets.  Un aspect de ceci inclut une th\u00e9rapie par ARNm enferm\u00e9 dans une nanoparticule lipidique.  L\u2019ARNm code pour le CD40, un ligand transmembranaire pr\u00e9sent sur les cellules T activ\u00e9es.  Ces nanoparticules conduisent \u00e0 l&rsquo;expression du ligand dans les cellules canc\u00e9reuses, ce qui provoque la mort cellulaire \u00e0 m\u00e9diation immunitaire dans les tumeurs, qui \u00e0 son tour lib\u00e8re des charges d&rsquo;antig\u00e8nes tumoraux dans la zone environnante.<\/p>\n<p>Le deuxi\u00e8me volet de l\u2019attaque concerne les cellules dendritiques qui ont \u00e9t\u00e9 pr\u00e9lev\u00e9es sur un patient, trait\u00e9es \u00e0 l\u2019aide des m\u00eames nanoparticules charg\u00e9es d\u2019ARNm, puis r\u00e9introduites chez le patient.  Ces cellules r\u00e9agissent \u00e0 l\u2019expression accrue de CD40 produite par le premier ensemble de nanoparticules dans le tissu tumoral et reprogramment ensuite le microenvironnement tumoral pour le rendre plus sensible \u00e0 d\u2019autres attaques immunitaires.      <\/p>\n<p>\u00ab\u00a0Les cellules dendritiques ont jou\u00e9 un r\u00f4le cl\u00e9 dans le d\u00e9veloppement de nouvelles th\u00e9rapies contre le cancer, car ces cellules organisent le cycle cancer-immunit\u00e9\u00a0\u00bb, a d\u00e9clar\u00e9 Brian Brown, un autre chercheur impliqu\u00e9 dans l&rsquo;\u00e9tude.  \u00ab\u00a0En th\u00e9orie, le r\u00e9gime CATCH utilisant cette technologie particuli\u00e8re bas\u00e9e sur l&rsquo;ARN a le potentiel de fournir une approche beaucoup plus efficace pour utiliser les cellules dendritiques pour l&rsquo;immunoth\u00e9rapie du cancer afin de traiter un large \u00e9ventail de tumeurs solides.\u00a0\u00bb<\/p>\n<p>\u00c9tude dans un journal <em>Nature Nanotechnologie<\/em>: Fermer le cycle cancer-immunit\u00e9 en int\u00e9grant des formulations de nanoparticules lipidiques \u2013 ARNm et la th\u00e9rapie cellulaire dendritique<\/p>\n<p>Via : H\u00f4pital Mont Sina\u00ef<\/p>\n<p><!--TrendMD v2.4.8--><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Des chercheurs de l\u2019H\u00f4pital Mount Sinai ont d\u00e9velopp\u00e9 un traitement contre le cancer bas\u00e9 sur l\u2019ARNm. L\u2019approche combine l\u2019administration d\u2019une<\/p>\n","protected":false},"author":1,"featured_media":1422,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1287,1310,1687,1719,1424],"class_list":["post-1421","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classe","tag-arnm","tag-cancer","tag-cible","tag-limmunotherapie","tag-linkidoc","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>L&#039;immunoth\u00e9rapie \u00e0 ARNm cible le cancer | Linkidoc - Blog Linkidoc : consultant e-sant\u00e9<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L&#039;immunoth\u00e9rapie \u00e0 ARNm cible le cancer | Linkidoc - Blog Linkidoc : consultant e-sant\u00e9\" \/>\n<meta property=\"og:description\" content=\"Des chercheurs de l\u2019H\u00f4pital Mount Sinai ont d\u00e9velopp\u00e9 un traitement contre le cancer bas\u00e9 sur l\u2019ARNm. L\u2019approche combine l\u2019administration d\u2019une\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog Linkidoc : consultant e-sant\u00e9\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Linkidoc-1405583326346119\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-26T01:08:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-26T01:08:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.linkidoc.fr\/blog\/wp-content\/uploads\/2023\/08\/1693012103_Limmunotherapie-a-ARNm-cible-le-cancer-Linkidoc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"643\" \/>\n\t<meta property=\"og:image:height\" content=\"245\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@linkidoc\" \/>\n<meta name=\"twitter:site\" content=\"@linkidoc\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/#\/schema\/person\/a9d20772b98405a24e901c6e8b3f7979\"},\"headline\":\"L&rsquo;immunoth\u00e9rapie \u00e0 ARNm cible le cancer | Linkidoc\",\"datePublished\":\"2023-08-26T01:08:23+00:00\",\"dateModified\":\"2023-08-26T01:08:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/\"},\"wordCount\":577,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.linkidoc.fr\/blog\/wp-content\/uploads\/2023\/08\/1693012103_Limmunotherapie-a-ARNm-cible-le-cancer-Linkidoc.jpg\",\"keywords\":[\"ARNm\",\"cancer\",\"cible\",\"Limmunoth\u00e9rapie\",\"Linkidoc\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/\",\"url\":\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/\",\"name\":\"L'immunoth\u00e9rapie \u00e0 ARNm cible le cancer | Linkidoc - Blog Linkidoc : consultant e-sant\u00e9\",\"isPartOf\":{\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.linkidoc.fr\/blog\/wp-content\/uploads\/2023\/08\/1693012103_Limmunotherapie-a-ARNm-cible-le-cancer-Linkidoc.jpg\",\"datePublished\":\"2023-08-26T01:08:23+00:00\",\"dateModified\":\"2023-08-26T01:08:24+00:00\",\"author\":{\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/#\/schema\/person\/a9d20772b98405a24e901c6e8b3f7979\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#primaryimage\",\"url\":\"https:\/\/www.linkidoc.fr\/blog\/wp-content\/uploads\/2023\/08\/1693012103_Limmunotherapie-a-ARNm-cible-le-cancer-Linkidoc.jpg\",\"contentUrl\":\"https:\/\/www.linkidoc.fr\/blog\/wp-content\/uploads\/2023\/08\/1693012103_Limmunotherapie-a-ARNm-cible-le-cancer-Linkidoc.jpg\",\"width\":643,\"height\":245,\"caption\":\"L'immunoth\u00e9rapie \u00e0 ARNm cible le cancer | Medgadget\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.linkidoc.fr\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L&rsquo;immunoth\u00e9rapie \u00e0 ARNm cible le cancer | Linkidoc\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/#website\",\"url\":\"https:\/\/www.linkidoc.fr\/blog\/\",\"name\":\"Blog Linkidoc : consultant e-sant\u00e9\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.linkidoc.fr\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.linkidoc.fr\/blog\/#\/schema\/person\/a9d20772b98405a24e901c6e8b3f7979\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/14eda662a647a4155a7a1d02e7bfcaa3bb481e49c034ede0c8f80e32c0c758b8?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/14eda662a647a4155a7a1d02e7bfcaa3bb481e49c034ede0c8f80e32c0c758b8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/14eda662a647a4155a7a1d02e7bfcaa3bb481e49c034ede0c8f80e32c0c758b8?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/www.linkidoc.fr\/blog\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L'immunoth\u00e9rapie \u00e0 ARNm cible le cancer | Linkidoc - Blog Linkidoc : consultant e-sant\u00e9","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/","og_locale":"fr_FR","og_type":"article","og_title":"L'immunoth\u00e9rapie \u00e0 ARNm cible le cancer | Linkidoc - Blog Linkidoc : consultant e-sant\u00e9","og_description":"Des chercheurs de l\u2019H\u00f4pital Mount Sinai ont d\u00e9velopp\u00e9 un traitement contre le cancer bas\u00e9 sur l\u2019ARNm. L\u2019approche combine l\u2019administration d\u2019une","og_url":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/","og_site_name":"Blog Linkidoc : consultant e-sant\u00e9","article_publisher":"https:\/\/www.facebook.com\/Linkidoc-1405583326346119\/","article_published_time":"2023-08-26T01:08:23+00:00","article_modified_time":"2023-08-26T01:08:24+00:00","og_image":[{"width":643,"height":245,"url":"https:\/\/www.linkidoc.fr\/blog\/wp-content\/uploads\/2023\/08\/1693012103_Limmunotherapie-a-ARNm-cible-le-cancer-Linkidoc.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@linkidoc","twitter_site":"@linkidoc","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#article","isPartOf":{"@id":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/"},"author":{"name":"admin","@id":"https:\/\/www.linkidoc.fr\/blog\/#\/schema\/person\/a9d20772b98405a24e901c6e8b3f7979"},"headline":"L&rsquo;immunoth\u00e9rapie \u00e0 ARNm cible le cancer | Linkidoc","datePublished":"2023-08-26T01:08:23+00:00","dateModified":"2023-08-26T01:08:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/"},"wordCount":577,"commentCount":0,"image":{"@id":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.linkidoc.fr\/blog\/wp-content\/uploads\/2023\/08\/1693012103_Limmunotherapie-a-ARNm-cible-le-cancer-Linkidoc.jpg","keywords":["ARNm","cancer","cible","Limmunoth\u00e9rapie","Linkidoc"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/","url":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/","name":"L'immunoth\u00e9rapie \u00e0 ARNm cible le cancer | Linkidoc - Blog Linkidoc : consultant e-sant\u00e9","isPartOf":{"@id":"https:\/\/www.linkidoc.fr\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#primaryimage"},"image":{"@id":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.linkidoc.fr\/blog\/wp-content\/uploads\/2023\/08\/1693012103_Limmunotherapie-a-ARNm-cible-le-cancer-Linkidoc.jpg","datePublished":"2023-08-26T01:08:23+00:00","dateModified":"2023-08-26T01:08:24+00:00","author":{"@id":"https:\/\/www.linkidoc.fr\/blog\/#\/schema\/person\/a9d20772b98405a24e901c6e8b3f7979"},"breadcrumb":{"@id":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#primaryimage","url":"https:\/\/www.linkidoc.fr\/blog\/wp-content\/uploads\/2023\/08\/1693012103_Limmunotherapie-a-ARNm-cible-le-cancer-Linkidoc.jpg","contentUrl":"https:\/\/www.linkidoc.fr\/blog\/wp-content\/uploads\/2023\/08\/1693012103_Limmunotherapie-a-ARNm-cible-le-cancer-Linkidoc.jpg","width":643,"height":245,"caption":"L'immunoth\u00e9rapie \u00e0 ARNm cible le cancer | Medgadget"},{"@type":"BreadcrumbList","@id":"https:\/\/www.linkidoc.fr\/blog\/2023\/08\/26\/limmunotherapie-a-arnm-cible-le-cancer-linkidoc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.linkidoc.fr\/blog\/"},{"@type":"ListItem","position":2,"name":"L&rsquo;immunoth\u00e9rapie \u00e0 ARNm cible le cancer | Linkidoc"}]},{"@type":"WebSite","@id":"https:\/\/www.linkidoc.fr\/blog\/#website","url":"https:\/\/www.linkidoc.fr\/blog\/","name":"Blog Linkidoc : consultant e-sant\u00e9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.linkidoc.fr\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.linkidoc.fr\/blog\/#\/schema\/person\/a9d20772b98405a24e901c6e8b3f7979","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/14eda662a647a4155a7a1d02e7bfcaa3bb481e49c034ede0c8f80e32c0c758b8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/14eda662a647a4155a7a1d02e7bfcaa3bb481e49c034ede0c8f80e32c0c758b8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/14eda662a647a4155a7a1d02e7bfcaa3bb481e49c034ede0c8f80e32c0c758b8?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/www.linkidoc.fr\/blog"]}]}},"_links":{"self":[{"href":"https:\/\/www.linkidoc.fr\/blog\/wp-json\/wp\/v2\/posts\/1421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.linkidoc.fr\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.linkidoc.fr\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.linkidoc.fr\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.linkidoc.fr\/blog\/wp-json\/wp\/v2\/comments?post=1421"}],"version-history":[{"count":0,"href":"https:\/\/www.linkidoc.fr\/blog\/wp-json\/wp\/v2\/posts\/1421\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.linkidoc.fr\/blog\/wp-json\/wp\/v2\/media\/1422"}],"wp:attachment":[{"href":"https:\/\/www.linkidoc.fr\/blog\/wp-json\/wp\/v2\/media?parent=1421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.linkidoc.fr\/blog\/wp-json\/wp\/v2\/categories?post=1421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.linkidoc.fr\/blog\/wp-json\/wp\/v2\/tags?post=1421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}